Vistide (cidofovir) - Important Safety Information from Gilead as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 19/01/2011

Problem Or Issue:

Important Safety Information communication from Gilead regarding serious adverse reactions following off-label use of Vistide

« Back